FDA Approves New Treatment for Anthrax

Share this content:
FDA Approves New Treatment for Anthrax
FDA Approves New Treatment for Anthrax

WEDNESDAY, March 25, 2015 (HealthDay News) -- Anthrasil, Anthrax Immune Globulin Intravenous (Human), has been approved by the U.S. Food and Drug Administration to treat patients with inhalational anthrax in combination with appropriate antibacterial drugs.

Anthrasil is sanctioned, when combined with approved antibiotics, to support the nation's preparedness against a possible anthrax attack, the FDA said Wednesday in a news release. Other rare but possible means of human exposure to the deadly bacteria include infected animals or contaminated animal products.

Anthrasil is made from the plasma of people who have been vaccinated against anthrax. The plasma includes antibodies that neutralize toxins produced by anthrax, the FDA said. The drug will be stored in the U.S. Strategic National Stockpile for use in an "anthrax emergency."

Because it wasn't "feasible or ethical" to expose people to anthrax, Anthrasil's effectiveness was tested in rabbits and monkeys, the agency said. The vaccine's safety was evaluated among 74 healthy people who weren't exposed to anthrax. The most common side effects included headache, back pain, nausea, and pain and swelling at the injection site.

Anthrasil is produced by Cangene Corp., based in Winnipeg, Canada.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »